Cargando…
Antisense oligonucleotide: A promising therapeutic option to beat COVID‐19
The COVID‐19 crisis and the development of the first approved mRNA vaccine have highlighted the power of RNA‐based therapeutic strategies for the development of new medicines. Aside from RNA‐vaccines, antisense oligonucleotides (ASOs) represent a new and very promising class of RNA‐targeted therapy....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011570/ https://www.ncbi.nlm.nih.gov/pubmed/34842345 http://dx.doi.org/10.1002/wrna.1703 |